1. Home
  2. CCLD vs SGMO Comparison

CCLD vs SGMO Comparison

Compare CCLD & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareCloud Inc.

CCLD

CareCloud Inc.

HOLD

Current Price

$3.30

Market Cap

133.1M

Sector

Technology

ML Signal

HOLD

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.45

Market Cap

155.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCLD
SGMO
Founded
1999
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
133.1M
155.1M
IPO Year
2014
2000

Fundamental Metrics

Financial Performance
Metric
CCLD
SGMO
Price
$3.30
$0.45
Analyst Decision
Hold
Buy
Analyst Count
1
7
Target Price
$1.50
$4.71
AVG Volume (30 Days)
326.4K
9.2M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$114,315,000.00
$32,875,000.00
Revenue This Year
$8.58
$1.37
Revenue Next Year
$12.06
N/A
P/E Ratio
$43.20
N/A
Revenue Growth
2.97
N/A
52 Week Low
$1.14
$0.38
52 Week High
$4.75
$2.84

Technical Indicators

Market Signals
Indicator
CCLD
SGMO
Relative Strength Index (RSI) 58.60 43.51
Support Level $3.04 $0.49
Resistance Level $3.35 $0.51
Average True Range (ATR) 0.12 0.04
MACD 0.04 0.01
Stochastic Oscillator 85.00 31.04

Price Performance

Historical Comparison
CCLD
SGMO

About CCLD CareCloud Inc.

CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: